New therapeutic approaches to overcoming resistant EGFR exon 20 alterations - ScienceDirect
Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer | Signal Transduction and Targeted Therapy
Conformational Landscapes of HER2 Exon 20 Insertions Explain Their Sensitivity to Kinase Inhibitors in Lung Adenocarcinoma - ScienceDirect
Novel drugs targeting EGFR and HER2 exon 20 mutations in metastatic NSCLC - ScienceDirect
Frontiers | HER2 Exon 20 Insertion Mutations in Lung Adenocarcinoma: Case Series and Response to Pyrotinib
Inhibition of EGFR Signaling: All Mutations Are Not Created Equal | PLOS Medicine
Cancers | Free Full-Text | EGFR Exon 20 Insertion in Metastatic Non-Small-Cell Lung Cancer: Survival and Clinical Efficacy of EGFR Tyrosine-Kinase Inhibitor and Chemotherapy
Discovery of potent and selective HER2 inhibitors with efficacy against HER2 exon 20 insertion-driven tumors, which preserve wild-type EGFR signaling | Nature Cancer
EGFR exon 20 insertion mutations and response to osimertinib in non-small-cell lung cancer | BMC Cancer | Full Text
Hitting the target in HER2 mutant cancers | Nature Cancer
![PDF] EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/debf33b1a59509923198bf4df9e79bb7da7e72f8/8-Figure3-1.png "PDF] EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics | Semantic Scholar")
PDF] EGFR Exon 20 Insertion Mutations in Lung Adenocarcinomas: Prevalence, Molecular Heterogeneity, and Clinicopathologic Characteristics | Semantic Scholar
Purpose
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment | Nature Reviews Clinical Oncology
Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer | Signal Transduction and Targeted Therapy
Exon 20 insertion mutations induce de novo resistance to covalent and... | Download Scientific Diagram
Frontiers | Specific HER2 Exon 20 Gly776 Deletion-Insertions in Non-Small Cell Lung Cancer: Structural Analysis and Sensitivity to HER2-Targeted Tyrosine Kinase Inhibitors
Pharmaceuticals | Free Full-Text | HER2 Aberrations in Non-Small Cell Lung Cancer: From Pathophysiology to Targeted Therapy
New therapeutic approaches to overcoming resistant EGFR exon 20 alterations Alex M Lia (aml098@ucsd.edu), Amélie Boichardb (abo
Extensive functional evaluation of exon 20 insertion mutations of EGFR - ScienceDirect
EGFR exon 20 insertion mutations in advanced non-small-cell lung cancer: current status and perspectives | Biomarker Research | Full Text
EGFR and ERBB2 exon 20 insertions and sensitivity to covalent... | Download Scientific Diagram
EGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment | Nature Reviews Clinical Oncology
